Sector
PharmaceuticalsOpen
₹43.9Prev. Close
₹42.29Turnover(Lac.)
₹6.75Day's High
₹43.9Day's Low
₹41.152 Week's High
₹73.952 Week's Low
₹33.52Book Value
₹14.28Face Value
₹10Mkt Cap (₹ Cr.)
165.75P/E
61.29EPS
0.69Divi. Yield
04 Aug 2023
12:00 AM
BookCloser
25 Jun 2024
12:00 AM
Board Meeting
Agenda : Audited Result
4 Aug 2023
12:00 AM
AGM
Announcement Date: 04 Aug, 2023
22 Sep 2023
12:00 AM
Rights
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 39.86 | 31.89 | 24.18 | 21.66 |
Preference Capital | 0 | 0 | 0 | 1 |
Reserves | 17.09 | -9.59 | -17.24 | -15.54 |
Net Worth | 56.95 | 22.3 | 6.94 | 7.12 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 68.49 | 76.92 | 93.1 | 66.51 |
yoy growth (%) | -10.95 | -17.38 | 39.98 | 430.71 |
Raw materials | -60.85 | -68.43 | -83.32 | -58.26 |
As % of sales | 88.85 | 88.96 | 89.49 | 87.59 |
Employee costs | -4.09 | -2.99 | -2.95 | -2.46 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -7.31 | -2.2 | 1.5 | 0.78 |
Depreciation | -2.35 | -2.14 | -2.14 | -2.08 |
Tax paid | 1.74 | 0.34 | -0.75 | -0.26 |
Working capital | 8.78 | -2.03 | 0.93 | 1.09 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -10.95 | -17.38 | 39.98 | 430.71 |
Op profit growth | 4,105.46 | -103.42 | 18.48 | -5,852.57 |
EBIT growth | 232.63 | -244.05 | 61.23 | -144.62 |
Net profit growth | 200.35 | -346.29 | 123.06 | -122.69 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director & MD
Ranjan Jain
E D & Wholetime Director
Suninder Veer Singh
Independent Non Exe. Director
Arshdeep Kaur
Non-Exec & Non-Independent Dir
Neena Batra
Independent Non Exe. Director
Renu Rawat
Company Sec. & Compli. Officer
Shikha Kataria
Non Executive Director
Vivek Trehan
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Syschem (India) Ltd
Summary
Syschem (India) Limited formerly known as Anil Pesticides Limited was incorporated in 1993 and promoted by Anil Nibber, Atul Nibber and Ajay Kumar Singla. The Company is engaged in the business of manufacturing of API / Intermediates. It has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt. Panchkula (Haryana).In 1996 the company went for launching new product called Monocrotophos and production was commisioned on 1998 only.The company expanded the installed capacity of Dichlorvos by 400 TPM in 2000.The company introduced new products namely Deta,DETC and Ethion in 2001. It is also planning for diversification plan by manufacturing new range of chemicals of compounds for various applications.The Company started commercial production of 7-ADCA key Drug Intermediate for Cephalosporin family of Bulk Drugs during year 2003-04. It added 2 new products like Fexa Fenadine Intermediate and THF during 2010. The Company changed its product line from Chemical manufacturing to Pharmaceutical Industry during the Financial Year 2017-2018.
Read More
What is the Syschem (India) Ltd share price today?
The Syschem (India) Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹41.58 today.
What is the Market Cap of Syschem (India) Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Syschem (India) Ltd is ₹165.75 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Syschem (India) Ltd?
The PE and PB ratios of Syschem (India) Ltd is 61.29 and 2.96 as of 22 Jul ‘24
What is the 52 Week High and Low of Syschem (India) Ltd?
The 52-week high/low is the highest and lowest price at which a Syschem (India) Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Syschem (India) Ltd is ₹33.52 and ₹73.9 as of 22 Jul ‘24
What is the CAGR of Syschem (India) Ltd?
Syschem (India) Ltd's CAGR for 5 Years at 40.92%, 3 Years at 75.98%, 1 Year at 21.45%, 6 Month at -37.86%, 3 Month at -31.82% and 1 Month at -9.37%.
What is the shareholding pattern of Syschem (India) Ltd?
The shareholding pattern of Syschem (India) Ltd is as follows:
Promoters - 53.89 %
Institutions - 0.25 %
Public - 45.86 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
